Bonjour ,
Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.
% complété
%
4 Ce profil est validé par 4 label.
Company
GlakoLens
63
EQ SCORE L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
An innovative diagnostic medical device company striving to aid ophthalmologists in the fight against ocular hypertension and glaucoma induced blindness by providing continuous intraocular pressure fluctuation data for 24 hours.
Istanbul, Istanbul, Turkey
Send a message
Anglais
GlakoLens
Anglais
GlakoLens is a medical devices company developing innovative biosensors based on proprietary technology, first of which is a non-invasive continuous intraocular pressure (IOP) monitoring device. The company’s strategy is to focus on introducing a single, state-of-the-art product at a time.
GlakoLens was co-founded as a technological spin-off from Boğaziçi University in 2017 by three distinguished academicians conducting research on biosensors, integrated circuits, MEMS and...
GlakoLens is a medical devices company developing innovative biosensors based on proprietary technology, first of which is a non-invasive continuous intraocular pressure (IOP) monitoring device. The company’s strategy is to focus on introducing a single, state-of-the-art product at a time.
GlakoLens was co-founded as a technological spin-off from Boğaziçi University in 2017 by three distinguished academicians conducting research on biosensors, integrated circuits, MEMS and electro-optical systems. They have been working together for more than a decade and have successfully completed several international collaborative R&D projects.
-
3
Followers
-
4
Like
Our latest news
GlakoLens Receives Seal of Excellence for its EIC Accelerator Submission
05.01.2021
GlakoLens scored 13.8/15 (ESR) in its first SME Instrument Phase 2 (EIC Accelerator) submission receiving its third Seal of Excellence Award from the European Commission with the project titled, SaveSight2: Contact Lens Embedded Sensor for Ocular Hypertension and Glaucoma Monitoring. The Seal of Excellence was awarded for the last cut-off of the EIC Accelerator program within the Horizon 2020 Framework, the most competitive round so far with more than 1700 submissions.
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded in a highly competitive evaluation process by independent experts but did not receive funding due to budget limits. This quality label is a guarantee for investors to find disruptive project proposals from European SMEs with high growth potential.
GlakoLens: BIO Startup Turkey Finalist
02.04.2021
GlakoLens attended the fifth BIO Startup Turkey accelerator program organized by ReDis Innovation with 12 bio-entrepreneurs. During the program, GlakoLens received one-to-one mentoring and online trainings from experts and leading industry professionals. Following the bio-entrepreneurship camp, GlakoLens pitched in the BIO Startup Demo Day.
By becoming one of the finalists, GlakoLens is going to attend BIO International Convention, the world’s largest global biotech partnering experience.
GlakoLens is participating in the Healthcare Validation Lab Bootcamp
13.08.2020
GlakoLens is selected to participate in the Healthcare Validation Lab Bootcamp, ...
GlakoLens is participating in the Healthcare Validation Lab Bootcamp
13.08.2020
GlakoLens is selected to participate in the Healthcare Validation Lab Bootcamp, an EIT (European Institute of Innovation and Technology) Health programme provided by YES!Delft, the accelerator of TU Delft.
Participation in this project enables GlakoLens to collect user requirements from a large group of customers (ophthalmologists and patients) making use of proven and credible methodologies. Additionally, the activities conducted in this bootcamp will validate the product-market fit: the customer demand and economic feasibility.
GlakoLens will use the information mined during this accelerator activity to improve the design (or use) of the product within the design control system of GlakoLens and possibly lead to new inventions of innovations.
Hello Tomorrow Deep Tech Pioneer
We’ve been named one of Hello Tomorrow's Deep Tech Pioneers! Selected among more than 5,000 startups from 128 different countries that applied to the Global Challenge. Come and meet us at the Hello Tomorrow Global Summit in Paris on 12th-13th March 2020!
SME Instrument Champion
We are proud to announce that our SME Instrument Phase 1 proposal has been awarded this competitive and prestigious grant from the European Community. Our ESR score of 13.91 placed us 89th among the 3275 apllications filed in the last cut-off. This project will enable GlakoLens to conduct an in-depth technical and economic feasibility study culminating into an updated business plan focusing on global commercialization of our innovative technology.
The proprietary technology of GlakoLens will provide ophthalmologists with a powerful diagnostic tool, GlakoSense Platform, in the fight against glaucoma induced blindness. We are foreseeing a future where an early diagnosis of ocular hypertension will prevent deterioration of quality of life due to sight loss and consequent economic and social burden on societies.
- slide 1 of 5
- slide 2 of 5, currently active
- slide 3 of 5
- slide 4 of 5
- slide 5 of 5
Team member(s)
Your request has been sent
Founder(s)
Employee(s)
Join this organization
Your request has been sent
Team member(s)
Founder(s)
Our network
Your request has been sent
Partner
Join this network
Your message has been sent
Certifications
This label is a guarantee for investors to discover selected companies benefiting from Business acceleration services provided by the European Commission.
154 Entities
Eureka is the world’s leading network for international R&D collaborations, represented in over 45 countries.
It aims to boost the growth of SMEs, large companies, research organisations and universities through funding and supporting international R&D cooperation and providing investment-readiness services
Through Eureka’s programmes, organisations can access funding and expert support. The Eureka label is given to companies who have been financed through Eureka programmes.
215 Entities
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities
The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020 which succeeded a highly competitive evaluation process by independent experts, but did not receive funding due to budget limits.
This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential.
1478 Entities
Communities
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding
for selected DEEP TECH companies.
2667 Members
The Access2EIC -Seal of Excellence community aims at gathering high potential European companies that received from the European Commission a “Seal of Excellence” certificate and European equity investors.
https://access2eic.eu/
2140 Members